Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
+9,642
New +$1.98M 0.13% 38
2025
Q1
Sell
-19,831
Closed -$2.66M 38
2024
Q4
$2.66M Sell
19,831
-719
-3% -$99.1K 0.2% 31
2024
Q3
$2.5M Buy
20,550
+7,250
+55% +$856K 0.18% 33
2024
Q2
$1.64M Hold
13,300
0.12% 32
2024
Q1
$1.2M Sell
13,300
-3,200
-19% -$232K 0.14% 34
2023
Q4
$817K Hold
16,500
0.1% 31
2023
Q3
$718K Buy
+16,500
New +$739K 0.1% 30

Other funds holding NVDA

M.D. Sass LLC's NVDA Position: Q2 2026 in Review

M.D. Sass LLC opened a new position in NVIDIA (NVDA) in Q2 2026: 9,642 shares worth $1.93M. The stake represents 0.13% of the portfolio and ranks #38 among its holdings. This is a return to the name: M.D. Sass LLC previously reported a position in NVDA as recently as Q4 2024.

M.D. Sass LLC first reported a position in NVDA in Q3 2023 and has held it in 7 quarters since. The position peaked at $2.66M in Q4 2024. 5,964 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

  • M.D. Sass LLC held 9,642 shares of NVIDIA worth $1.93M as of Q2 2026.
  • NVIDIA was a new M.D. Sass LLC position in Q2 2026.
  • NVIDIA made up 0.13% of M.D. Sass LLC's portfolio in Q2 2026, its #38 holding.
  • M.D. Sass LLC first reported a position in NVIDIA in Q3 2023 and has held it in 7 quarters since.
  • M.D. Sass LLC's NVIDIA position peaked at $2.66M in Q4 2024.
  • 5,964 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on M.D. Sass LLC's 13F filing for Q2 2026, filed 7 Aug 2026.